Equifax Inc.

NYSE:EFX Voorraadrapport

Marktkapitalisatie: US$20.9b

Equifax Toekomstige groei

Future criteriumcontroles 3/6

Equifax zal naar verwachting groeien in winst en omzet met respectievelijk 17.3% en 8.4% per jaar. De winst per aandeel zal naar verwachting groeien met 19.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 27% zijn.

Belangrijke informatie

17.3%

Groei van de winst

19.14%

Groei van de winst per aandeel

Professional Services winstgroei15.4%
Inkomstengroei8.4%
Toekomstig rendement op eigen vermogen27.00%
Dekking van analisten

Good

Laatst bijgewerkt11 May 2026

Recente toekomstige groei-updates

Recent updates

Seeking Alpha May 06

Equifax: Downgrading To Hold On Near-Term Uncertainty

Summary Equifax is downgraded to hold after a strong Q1 2026, with concerns about the sustainability of growth and margin leverage. Q1 revenue grew 14% y/y to $1.65B, driven by mortgage activity and robust Workforce Solutions (EWS) performance. Management did not raise 2026 guidance despite the beat, signaling caution on the earnings outlook and macro-driven mortgage recovery. EFX’s valuation is undemanding, but lack of margin expansion and mortgage dependency limit near-term rerating potential. Read the full article on Seeking Alpha
Analyse-update Apr 25

EFX: AI And Marketing Reset Will Support Long Term Earnings Power

Analysts trimmed the Equifax fair value estimate by about $7 to $229.19. Lower price targets from several firms, slightly higher discount rate assumptions, and a reduced revenue growth outlook were only partly balanced by a higher projected profit margin and a lower future P/E multiple.
Analyse-update Apr 11

EFX: AI Credit Tools And Marketing Reset Will Support Future Upside

Analysts have slightly reduced the average Equifax price target, with a modeled fair value moving from about $237.35 to $236.05. This change reflects updated views on discount rates, growth assumptions and recent target cuts across the Street.
Analyse-update Mar 26

EFX: AI Credit Tools And Marketing Shift Will Support Future Upside

Analysts have made only a small trim to the Equifax fair value estimate to $237.35, as recent price target cuts sit alongside views that the $1 VantageScore pricing move is mainly marketing and that sector wide expectations for revenue, EPS and free cash flow growth remain intact. Analyst Commentary Recent commentary around Equifax reflects a split between analysts who see the latest headlines as more noise than substance and those who are recalibrating their assumptions and price targets more cautiously.
Analyse-update Mar 11

EFX: AI Credit Tools And Buy Rating Will Shape Future Upside

Analysts have trimmed their average price target for Equifax by about $1 to $237.60, reflecting slightly higher discount rate assumptions, even as they factor in modestly stronger revenue growth, somewhat lower profit margins, and a higher future P/E after a recent wave of target reductions, alongside a fresh $250 Buy-level target from BofA. Analyst Commentary Recent Street research around Equifax reflects a mix of optimism on the long term earnings profile and caution around execution risks and valuation, especially after a cluster of price target cuts.
Analyse-update Feb 23

EFX: Credit Score Shift And AI Tools Will Shape Future Upside

Analysts have modestly trimmed their aggregate fair value estimate for Equifax to about $238.55 from $243.15, reflecting slightly higher discount rate and lower profit margin assumptions, while they continue to reference supportive long term growth expectations and a recent $250 price target from renewed coverage. Analyst Commentary Recent Street research on Equifax reflects a mix of cautious recalibration and ongoing confidence in the company’s long term earnings power.
Analyse-update Feb 08

EFX: Credit Score Shift And AI Risk Tools Will Support Future Upside

Analysts have trimmed their price targets on Equifax, reflected in a lower fair value estimate from $262.75 to $243.15, as they recalibrate P/E expectations and discount rates following a series of target cuts across the Street, while still modeling steady revenue growth and profit margins. Analyst Commentary Recent Street research on Equifax shows a clear reset in expectations, with a cluster of firms cutting price targets by amounts ranging from the mid teens to the low $40s.
Analyse-update Jan 24

EFX: Credit Score Competition And AI Fraud Tools Will Support Future Upside

Analysts have trimmed their price target on Equifax by about US$2 to US$262.75, citing updated assumptions around revenue growth, profit margins and future P/E that slightly adjust their overall valuation view. What's in the News The Federal Housing Finance Agency opened the door for VantageScore to compete with FICO in the home loan market, with Equifax, Experian and TransUnion owning VantageScore and potentially reshaping how mortgage credit scores are priced and sourced (Bloomberg).
Analyse-update Jan 08

EFX: High Entry Barriers Will Support Future Upside From Credit Score Competition

Analysts have trimmed their price targets on Equifax slightly, with one moving to a Hold at US$242 and another adjusting to US$271. These changes reflect updated views on growth, margins and future P/E assumptions following expected headwinds from FICO's Mortgage Direct License Program.
Analyse-update Dec 25

EFX: High Entry Barriers Will Support Future Outperformance Amid Mortgage Licensing Shift

Analysts have nudged their average price target for Equifax slightly lower, trimming fair value by approximately $0.50 to around $266.75 as they factor in modestly higher long term revenue growth and durable high quality assets, but also incremental earnings pressure and potential headwinds from FICO's new Mortgage Direct License Program. Analyst Commentary Analysts remain divided on Equifax, with views shaped by the competitive implications of FICO's Mortgage Direct License Program and the durability of Equifax's core data assets.
Analyse-update Dec 11

EFX: High Entry Barriers Will Sustain Resilience Amid FICO Mortgage License Headwinds

Analysts have nudged their average price target for Equifax slightly lower, trimming fair value by about $0.55 to roughly $267.25, as they factor in modestly higher long term headwinds from FICO's Mortgage Direct License Program and related credit bureau competition, despite still solid growth and margin assumptions. Analyst Commentary Street research reflects a mixed but generally constructive stance on Equifax, with views diverging around how disruptive FICO's Mortgage Direct License Program will ultimately be to the company's growth, margins, and valuation.
Analyse-update Nov 26

EFX: High Entry Barriers Will Sustain Core Resilience Amid Mortgage Score Disruption

Equifax's analyst price target has edged down by $0.50 to $267.80, as analysts cite near-term pressures on growth and profitability due to mortgage industry headwinds and changing competitive dynamics. Analyst Commentary Recent Street research highlights a mix of optimistic and cautious perspectives regarding Equifax's prospects, especially as the company navigates industry changes and competitive pressures.
Analyse-update Nov 09

EFX: Durable Competitive Advantages Will Offset Revenue Headwinds From Mortgage License Shift

Analysts have lowered their fair value estimate for Equifax to $268.30 from $272. They cite potential headwinds from industry changes and cautious revenue growth assumptions.
Analyse-update Oct 26

New Competitive Pressures And Regulatory Shifts Will Shape Market Leadership

Equifax's fair value estimate has been revised down from $277.70 to $272.00. Analysts cite ongoing revenue growth and margin pressures resulting from new industry headwinds and increased competition in the credit services market.
Analyse-update Oct 12

Government Verification And Cloud Migration Will Secure Future Advantage

Equifax's analyst price target has decreased from $280.50 to $277.70, as analysts note heightened industry headwinds and ongoing uncertainty following recent market and regulatory developments. Analyst Commentary Recent research reports highlight both opportunities and challenges for Equifax, as analysts adjust price targets and revisit expectations in light of evolving industry conditions and company-specific developments.
Analyse-artikel Jul 19

Returns On Capital Are Showing Encouraging Signs At Equifax (NYSE:EFX)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analyse-artikel Jun 22

Why Equifax Inc. (NYSE:EFX) Could Be Worth Watching

Let's talk about the popular Equifax Inc. ( NYSE:EFX ). The company's shares led the NYSE gainers with a relatively...
Analyse-artikel May 22

Equifax's (NYSE:EFX) Dividend Will Be Increased To $0.50

Equifax Inc. ( NYSE:EFX ) has announced that it will be increasing its dividend from last year's comparable payment on...
Seeking Alpha Apr 24

Equifax: Fundamentals Are Better Than Expected, But Macro Risks Haven't Cleared

Summary I maintain a hold rating on Equifax despite a strong 1Q25 performance, as macro risks like high mortgage rates and poor hiring trends persist. Equifax's 1Q25 results exceeded expectations with $1.442 billion revenue and a 29.3% adj. EBITDA margin, driven by growth in all segments. New growth drivers, including the SSA deal and The Work Number platform, are showing strong potential, enhancing Equifax's long-term outlook. Despite positive fundamentals, near-term caution is warranted due to volatile mortgage volumes and hiring trends, along with macroeconomic uncertainties. Read the full article on Seeking Alpha
Seeking Alpha Apr 14

Equifax Q1 Preview: Management's Thoughts On Outlook Should Be Interesting

Summary Analysts expect Equifax Inc.'s Q1 '25 results to show minimal growth, with EPS estimates at $1.41 adjusted and $1.00 GAAP on $1.42B revenue. Key concerns include weak U.S. mortgage and hiring markets, with 16 downward EPS revisions adding uncertainty to the upcoming results. Focus areas include U.S. mortgage inquiry declines, Workforce Solutions headwinds, and international performance, particularly in Brazil and Europe. Given the lackluster top-line growth and macroeconomic uncertainties, I don't recommend buying EFX stock before the earnings announcement. Read the full article on Seeking Alpha
Seeking Alpha Feb 11

Equifax: Near-Term Weakness That May Lead To Guidance Revision (Rating Downgrade)

Summary I am downgrading Equifax stock to a hold rating due to weak FY25 guidance, soft mortgage inquiry outlook, and hiring market pressures. Despite solid 4Q24 results and medium-term growth potential, the near-term earnings outlook is poor with decelerating revenue and EPS growth. Elevated mortgage rates and declining hiring volumes are significant headwinds, limiting EFX's ability to sustain recent growth rates. The current 30x forward P/E valuation lacks margin of safety; I prefer waiting for a better entry point or clearer macro recovery signs. Read the full article on Seeking Alpha
Seeking Alpha Jan 07

The 'New Equifax' Will Be More Profitable On New Cloud

Summary Equifax's transition to its own cloud and EFX.AI capabilities will drive revenue growth, margin expansion, and increased free cash flow, enhancing profitability. Lower CapEx and higher margins will boost earnings, with EPS expected to grow significantly, supporting a one-year price target of $306.75 and a Strong Buy rating. The new cloud platform will improve productivity, benefiting shareholders with increased returns. Despite recent stock volatility, the anticipated growth and financial benefits justify a 20.29% price increase, aligning with Wall Street analysts' positive outlook. Read the full article on Seeking Alpha

Winst- en omzetgroeiprognoses

NYSE:EFX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20288,1181,2221,5722,12214
12/31/20277,3901,0211,2751,76722
12/31/20266,7668441,0741,54122
3/31/20266,2816991,1391,634N/A
12/31/20256,0756601,1341,616N/A
9/30/20255,9436599991,470N/A
6/30/20255,8406409171,389N/A
3/31/20255,7346128091,296N/A
12/31/20245,6816048131,325N/A
9/30/20245,5885637841,322N/A
6/30/20245,4665836751,224N/A
3/31/20245,3535586441,219N/A
12/31/20235,2655455161,117N/A
9/30/20235,1375215081,120N/A
6/30/20235,0625244631,093N/A
3/31/20235,0615874801,107N/A
12/31/20225,122696133757N/A
9/30/20225,178710213817N/A
6/30/20225,156750312861N/A
3/31/20225,074764480993N/A
12/31/20214,9247448661,335N/A
9/30/20214,7896978021,247N/A
6/30/20214,6357207511,215N/A
3/31/20214,3836056131,059N/A
12/31/20204,128520525946N/A
9/30/20203,915470476880N/A
6/30/20203,722322-36348N/A
3/31/20203,619289-59314N/A
12/31/20193,508-384N/A314N/A
9/30/20193,437-382N/A248N/A
6/30/20193,396-425N/A565N/A
3/31/20193,393-347N/A584N/A
12/31/20183,412311N/A672N/A
9/30/20183,415447N/A715N/A
6/30/20183,416504N/A842N/A
3/31/20183,396525N/A832N/A
12/31/20173,362587N/A816N/A
9/30/20173,325538N/A888N/A
6/30/20173,294575N/A854N/A
3/31/20173,249540N/A819N/A
12/31/20163,145489N/A823N/A
9/30/20163,010478N/A750N/A
6/30/20162,873463N/A751N/A
3/31/20162,740443N/A747N/A
12/31/20152,664429N/A769N/A
9/30/20152,622415N/A740N/A
6/30/20152,568390N/A681N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei EFX ( 17.3% per jaar) ligt boven de spaarquote ( 3.5% ).

Winst versus markt: De winst van EFX ( 17.3% per jaar) zal naar verwachting sneller groeien dan de US markt ( 16.7% per jaar).

Hoge groeiwinsten: De winst van EFX zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van EFX ( 8.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.6% per jaar).

Hoge groei-inkomsten: De omzet van EFX ( 8.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen EFX zal naar verwachting over 3 jaar hoog zijn ( 27 %)


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/11 04:21
Aandelenkoers aan het einde van de dag2026/05/11 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Equifax Inc. wordt gevolgd door 33 analisten. 22 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jasper HellwegArgus Research Company
Jeffrey MeulerBaird
Manav PatnaikBarclays